McKercher H G, Mikhael N Z, De Gouffe M, Lukaszewski T, Peel H W
Res Commun Chem Pathol Pharmacol. 1986 Apr;52(1):141-4.
An extraction procedure is described that allows the application of a commercially available enzyme-multiplied immunoassay technique to the measurement of digoxin in whole blood, liver, and kidney. The concentrations of digoxin were measured in tissues obtained at autopsy from five patients who had been taking therapeutic doses of digoxin prior to death. Blood concentrations at autopsy were found to be higher than the therapeutic range, perhaps due to postmortem redistribution. Liver concentrations of digoxin showed a positive correlation with blood concentrations; this was not found for kidney concentrations of the drug.
本文描述了一种提取方法,该方法可将市售的酶放大免疫测定技术应用于全血、肝脏和肾脏中地高辛的测量。对五名生前服用治疗剂量地高辛的患者尸检获得的组织中的地高辛浓度进行了测量。尸检时的血药浓度高于治疗范围,这可能是由于死后再分布所致。肝脏中的地高辛浓度与血药浓度呈正相关;而该药物在肾脏中的浓度则未发现这种相关性。